Monitoring HIV-infected patients with diabetes: Hemoglobin A1c, fructosamine, or glucose?

So Young Kim, Patricia Friedmann, Amit Seth, Adrienne M. Fleckman

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

BACKGROUND: Published studies report inappropriately low hemoglobin A1C (HbA1c) values that underestimate glycemia in HIV patients.

METHODS: We reviewed the charts of all HIV patients with diabetes m ell it us (DM) at our clinic. Fifty-nine patients had HbA1c data, of whom 26 patients also had fructosamine data. We compared the most recent HbA1c to finger-stick (FS) glucose averaged over three months, and fructosamine to FS averaged over six weeks. Predicted average glucose (pAG) was calculated as reported by Nathan et al: pAG (mg/dL) = 28.7 × A1C% – 46.7. Data were analyzed using the Statistical Analysis System (SAS) and Kruskal–Wallis test.

RESULTS: HbA1c values underestimated (UE) actual average glucose (a AG) in 19% of these patients and overestimated (OE) aAG in 27%. HbA1c estimated aAG within the established range in only 54% of the patients. There were no statistical differences in the types of HIV medication used in patients with UE, OE, or accurately estimated (AE) glycemia. A Spearman correlation coefficient between HbA1c and aAG was r = 0.53 (P < 0.0001). Correlation between fructosamine and aAG was r = 0.47 (P = 0.016).

CONCLUSIONS: Te correlations between HbA1c and aAG and between fructosamine and aAG were weaker than expected, and fructosamine was not more accurate than HbA1c.

Original languageEnglish (US)
Pages (from-to)41-45
Number of pages5
JournalClinical Medicine Insights: Endocrinology and Diabetes
Volume7
DOIs
StatePublished - Dec 4 2014
Externally publishedYes

Fingerprint

Fructosamine
Hemoglobins
HIV
Glucose
Fingers

Keywords

  • A1C
  • Diabetes
  • Fructosamine
  • Glucose
  • HIV

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Monitoring HIV-infected patients with diabetes : Hemoglobin A1c, fructosamine, or glucose? / Kim, So Young; Friedmann, Patricia; Seth, Amit; Fleckman, Adrienne M.

In: Clinical Medicine Insights: Endocrinology and Diabetes, Vol. 7, 04.12.2014, p. 41-45.

Research output: Contribution to journalArticle

@article{9a79f36b79ad42a2b9e6b1f2e2a027e7,
title = "Monitoring HIV-infected patients with diabetes: Hemoglobin A1c, fructosamine, or glucose?",
abstract = "BACKGROUND: Published studies report inappropriately low hemoglobin A1C (HbA1c) values that underestimate glycemia in HIV patients.METHODS: We reviewed the charts of all HIV patients with diabetes m ell it us (DM) at our clinic. Fifty-nine patients had HbA1c data, of whom 26 patients also had fructosamine data. We compared the most recent HbA1c to finger-stick (FS) glucose averaged over three months, and fructosamine to FS averaged over six weeks. Predicted average glucose (pAG) was calculated as reported by Nathan et al: pAG (mg/dL) = 28.7 × A1C{\%} – 46.7. Data were analyzed using the Statistical Analysis System (SAS) and Kruskal–Wallis test.RESULTS: HbA1c values underestimated (UE) actual average glucose (a AG) in 19{\%} of these patients and overestimated (OE) aAG in 27{\%}. HbA1c estimated aAG within the established range in only 54{\%} of the patients. There were no statistical differences in the types of HIV medication used in patients with UE, OE, or accurately estimated (AE) glycemia. A Spearman correlation coefficient between HbA1c and aAG was r = 0.53 (P < 0.0001). Correlation between fructosamine and aAG was r = 0.47 (P = 0.016).CONCLUSIONS: Te correlations between HbA1c and aAG and between fructosamine and aAG were weaker than expected, and fructosamine was not more accurate than HbA1c.",
keywords = "A1C, Diabetes, Fructosamine, Glucose, HIV",
author = "Kim, {So Young} and Patricia Friedmann and Amit Seth and Fleckman, {Adrienne M.}",
year = "2014",
month = "12",
day = "4",
doi = "10.4137/CMED.S19202",
language = "English (US)",
volume = "7",
pages = "41--45",
journal = "Clinical Medicine Insights: Endocrinology and Diabetes",
issn = "1179-5514",
publisher = "Libertas Academica Ltd.",

}

TY - JOUR

T1 - Monitoring HIV-infected patients with diabetes

T2 - Hemoglobin A1c, fructosamine, or glucose?

AU - Kim, So Young

AU - Friedmann, Patricia

AU - Seth, Amit

AU - Fleckman, Adrienne M.

PY - 2014/12/4

Y1 - 2014/12/4

N2 - BACKGROUND: Published studies report inappropriately low hemoglobin A1C (HbA1c) values that underestimate glycemia in HIV patients.METHODS: We reviewed the charts of all HIV patients with diabetes m ell it us (DM) at our clinic. Fifty-nine patients had HbA1c data, of whom 26 patients also had fructosamine data. We compared the most recent HbA1c to finger-stick (FS) glucose averaged over three months, and fructosamine to FS averaged over six weeks. Predicted average glucose (pAG) was calculated as reported by Nathan et al: pAG (mg/dL) = 28.7 × A1C% – 46.7. Data were analyzed using the Statistical Analysis System (SAS) and Kruskal–Wallis test.RESULTS: HbA1c values underestimated (UE) actual average glucose (a AG) in 19% of these patients and overestimated (OE) aAG in 27%. HbA1c estimated aAG within the established range in only 54% of the patients. There were no statistical differences in the types of HIV medication used in patients with UE, OE, or accurately estimated (AE) glycemia. A Spearman correlation coefficient between HbA1c and aAG was r = 0.53 (P < 0.0001). Correlation between fructosamine and aAG was r = 0.47 (P = 0.016).CONCLUSIONS: Te correlations between HbA1c and aAG and between fructosamine and aAG were weaker than expected, and fructosamine was not more accurate than HbA1c.

AB - BACKGROUND: Published studies report inappropriately low hemoglobin A1C (HbA1c) values that underestimate glycemia in HIV patients.METHODS: We reviewed the charts of all HIV patients with diabetes m ell it us (DM) at our clinic. Fifty-nine patients had HbA1c data, of whom 26 patients also had fructosamine data. We compared the most recent HbA1c to finger-stick (FS) glucose averaged over three months, and fructosamine to FS averaged over six weeks. Predicted average glucose (pAG) was calculated as reported by Nathan et al: pAG (mg/dL) = 28.7 × A1C% – 46.7. Data were analyzed using the Statistical Analysis System (SAS) and Kruskal–Wallis test.RESULTS: HbA1c values underestimated (UE) actual average glucose (a AG) in 19% of these patients and overestimated (OE) aAG in 27%. HbA1c estimated aAG within the established range in only 54% of the patients. There were no statistical differences in the types of HIV medication used in patients with UE, OE, or accurately estimated (AE) glycemia. A Spearman correlation coefficient between HbA1c and aAG was r = 0.53 (P < 0.0001). Correlation between fructosamine and aAG was r = 0.47 (P = 0.016).CONCLUSIONS: Te correlations between HbA1c and aAG and between fructosamine and aAG were weaker than expected, and fructosamine was not more accurate than HbA1c.

KW - A1C

KW - Diabetes

KW - Fructosamine

KW - Glucose

KW - HIV

UR - http://www.scopus.com/inward/record.url?scp=84919352443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919352443&partnerID=8YFLogxK

U2 - 10.4137/CMED.S19202

DO - 10.4137/CMED.S19202

M3 - Article

AN - SCOPUS:84919352443

VL - 7

SP - 41

EP - 45

JO - Clinical Medicine Insights: Endocrinology and Diabetes

JF - Clinical Medicine Insights: Endocrinology and Diabetes

SN - 1179-5514

ER -